Earn $1000 Every Month From These 3 Stocks
https://www.fool.com/investing/2024/05/11/earn-1000-every-month-from-these-3-stocks/?source=iedfolrf0000001
May 11, 2024 - All 3 companies pay growing dividends.
0
Top Stock Reports for Amazon.com, Visa & Pfizer
https://www.zacks.com/commentary/2272277/top-stock-reports-for-amazon-com-visa-pfizer?cid=CS-ZC-FT-research_daily-2272277
May 10, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).
0
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
https://www.zacks.com/stock/news/2272311/pharma-stock-roundup-pfe-dmd-study-patient-death-fda-panel-meet-for-lly-s-donanemab?cid=CS-ZC-FT-analyst_blog|stock_roundup-2272311
May 10, 2024 - Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
0
2 Beaten-Down Stocks to Buy and Hold for 10 Years
https://www.fool.com/investing/2024/05/10/2-beaten-down-stocks-to-buy-and-hold-for-10-years/?source=iedfolrf0000001
May 10, 2024 - They offer plenty of upside and solid dividend growth.
0
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
https://www.zacks.com/stock/news/2268082/pharma-stock-roundup-lly-nvo-pfe-q1-results-jnj-s-new-plan-to-resolve-talc-claims?cid=CS-ZC-FT-analyst_blog|stock_roundup-2268082
May 03, 2024 - Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
0
Pfizer (PFE) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/05/01/pfizer-pfe-q1-2024-earnings-call-transcript/?source=iedfolrf0000001
May 01, 2024 - PFE earnings call for the period ending March 31, 2024.
0
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
https://www.zacks.com/stock/news/2265282/biontech-bntx-to-report-q1-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2265282
Apr 30, 2024 - On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.
0
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
https://www.zacks.com/stock/news/2265330/will-these-5-drug-biotech-stocks-beat-q1-earnings-forecast?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2265330
Apr 30, 2024 - Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
0
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
https://www.zacks.com/stock/news/2264363/here-s-how-to-play-pfizer-pfe-stock-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2264363
Apr 29, 2024 - Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
0
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
https://www.zacks.com/stock/news/2262623/bristol-myers-bmy-q1-loss-narrower-than-expected-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2262623
Apr 25, 2024 - Bristol-Myers' (BMY) first-quarter 2024 loss is narrower than estimated. Sales surpass the consensus mark on the back of Eliquis, Reblozyl and Opdualag's encouraging performance. However, Opdivo sales disappoint.
0